https://www.selleckchem.com/pr....oducts/pf-03084014-p
Our findings may help further delineate the phenotypic spectrum for trisomy 13 and may inform future research related to improving screening and counseling for the condition. To confirm the efficacy and safety of intra-articular injection of diclofenac covalently linked to hyaluronic acid (diclofenac etalhyaluronate [DF-HA] ONO-5704/SI-613). In a multicenter, randomized, placebo-controlled, double-blind phase 3 trial, eligible patients aged 40-75 years with symptomatic knee osteoarthritis (OA; Kellgren-Lawrence score of 2
Like
Comment
Share
